Grade 3-4 myelosuppression was reported in 33 ( 26 % ) of 128 patients who received treatment in the immediate chemotherapy group versus 24 ( 35 % ) of 68 patients who received treatment in the deferred chemotherapy group , neutropenia occurred in 49 ( 38 % ) versus 36 ( 53 % ) patients , respectively , and thrombocytopenia in 36 ( 28 % ) versus 26 ( 38 % ) .